QART Medical

3D Imaging System of Individual Sperm Cells

Health Tech & Life Sciences
Active
Series A Ra'anana Founded 2018
Total raised
Last: Series A 2024-03
Stage
Series A
Founded
2018
Headcount
8
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

Quantitative Assisted Reproductive Technologies (QART) Medical is a clinical-stage company developing a solution for highly informative characterization and selection of sperm cells for in vitro fertilization (IVF). The QART system aims to improve on the current success rates of intracytoplasmic sperm injection (ICSI) by quantitatively characterizing the morphology and contents of individual sperm cells with stain-free, real-time 3D topographic imaging, providing quantitative DNA integrity information on a cell-by-cell basis and automatically sorting a semen sample according to objective consensus criteria. The QART system is a compact, stand-alone benchtop clinical workstation. It is based upon a built-in quantitative phase interferometric microscopy (IPM) imaging microscopy platform and has a microfluidics sorting stage, all controlled via a simple personal computer. Per ICSI cycle, a disposable cartridge containing the semen specimen is inserted into the workstation.

Funding history · 3 rounds · — total

2024-03
Series A Undisclosed
2020-09
Seed Undisclosed
2019-03
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Simulation & Imaging
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

bioconvergencefemtechmedical-technologiesclinicspregnancyfertilityhospitalswomen-healthdiagnosticswomenreal-timedigital-healthcare3d-imagingdoctorsmonitoringdecision-support